"Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study" by Iain B. McInnes

Article

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study

Rheumatology (2017)

Iain B. McInnes, University of Glasgow
Philip J. Mease, University of Washington
Christopher T. Ritchlin, University of Rochester
Proton Rahman, St. John's University
Alice B. Gottlieb, New York Medical College
Bruce Kirkham, Guy's and St Thomas' NHS Foundation Trust
Radhika Kajekar, Novartis
Eumorphia-Maria Delicha, Novartis
Luminita Pricop, Novartis
Shephard Mpofu, Novartis

Link

Disciplines

Physical Therapy and
Medicine and Health Sciences

Publication Date

January 11, 2017

DOI

10.1093/rheumatology/kex301

Citation Information

Iain B. McInnes, Philip J. Mease, Christopher T. Ritchlin, Proton Rahman, et al.. "Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study" Rheumatology Vol. 56 Iss. 11 (2017) p. 1993 - 2003
Available at: http://works.bepress.com/philip-mease/48/